← All Cordovacann CORP filings

Cordovacann CORP 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink
LVRLF
Cordovacann CORP
20-F: CordovaCann Reports Increased Loss Amid Asset Sales & Control Weaknesses
CordovaCann Corp. reported a widened net loss for fiscal year 2025 despite revenue growth, driven by significant asset impairments and ongoing operational challenges, while also disclosing ineffective internal controls.
OTC.Pink
LVRLF
Cordovacann CORP
20-F/A: CordovaCann Corp. Files 20-F Annual Report for Fiscal Year Ended June 30, 2024
CordovaCann Corp. has filed its annual report on Form 20-F, detailing its financial results and operational activities for the fiscal year ended June 30, 2024.
OTC.Pink
LVRLF
Cordovacann CORP
20-F: CordovaCann Corp. Files 20-F Annual Report, Cites Ongoing Concerns Amidst Regulatory and Financial Challenges
CordovaCann Corp.'s 20-F filing reveals a complex financial landscape with ongoing operational and regulatory challenges, despite a slight revenue increase.